Bloomberg @business
GSK's vaccine for respiratory syncytial virus, or RSV, won the support of a key panel of US regulatory advisers for its safety in people 60 and older https://t.co/HapnVRhtN9 — PolitiTweet.org
Created
Wed Mar 01 20:25:37 +0000 2023
Likes
24
Retweets
6
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Bloomberg @business
GSK's vaccine for respiratory syncytial virus, or RSV, won the support of a key panel of US regulatory advisers for its safety in people 60 and older https://t.co/HapnVRhtN9 — PolitiTweet.org